Publications | Lund University Publications

1 – 5 of 5

show: 10
|
sort: year (new to old)

News feed Embed this list Save this search Mark all Export

Cancel

Embed this list

copy and paste the html snippet below into your own page:

<iframe src="https://lup.lub.lu.se/search/publication?embed=1&q=author%3D%22Parker%2C+Christopher%22+or+(documentType+any+%22bookEditor+conferenceEditor%22+and+editor%3D%22Parker%2C+Christopher%22)&amp;hide_pagination=1&amp;hide_info=1&amp;hide_options=1"
  width="100%"
  height="400"
  allowtransparency="true"
  frameborder="0">
</iframe>

2018
Mark Targeted Alpha Therapy, an Emerging Class of Cancer Agents : A Review
Parker, Christopher ; Lewington, Valerie ; Shore, Neal ; Kratochwil, Clemens ; Levy, Moshe ; Lindén, Ola ^LU ; Noordzij, Walter ; Park, Jae and Saad, Fred (2018) In JAMA Oncology 4(12). p.1765-1772
- Contribution to journal › Scientific review
2017
Mark The potential of ²²³Ra and ¹⁸F-fluoride imaging to predict bone lesion response to treatment with ²²³Ra-dichloride in castration-resistant prostate cancer
Murray, Iain ; Chittenden, Sarah J. ; Denis-Bacelar, Ana M. ; Hindorf, Cecilia ^LU ; Parker, Christopher ; Chua, Sue and Flux, Glenn D. (2017) In European Journal of Nuclear Medicine and Molecular Imaging p.1-13
- Contribution to journal › Article
2015
Mark A Phase 1, Open-Label Study of the Biodistribution, Pharmacokinetics, and Dosimetry of Ra-223-Dichloride in Patients with Hormone-Refractory Prostate Cancer and Skeletal Metastases
Chittenden, Sarah J. ; Hindorf, Cecilia ^LU ; Parker, Christopher C. ; Lewington, Valerie J. ; Pratt, Brenda E. ; Johnson, Bernadette and Flux, Glenn D. (2015) In Journal of Nuclear Medicine 56(9). p.1304-1309
- Contribution to journal › Article
2013
Mark Two-Year Survival Follow-Up of the Randomized, Double-Blind, Placebo-Controlled Phase II Study of Radium-223 Chloride in Patients With Castration-Resistant Prostate Cancer and Bone Metastases
Nilsson, Sten ; Franzen, Lars ; Parker, Christopher ; Tyrrell, Christopher ; Blom, Rene ; Tennvall, Jan ^LU ; Lennernas, Bo ; Petersson, Ulf ; Johannessen, Dag C. and Sokal, Michael , et al. (2013) In Clinical Genitourinary Cancer 11(1). p.20-26
- Contribution to journal › Article
2007
Mark Bone-targeted radium-223 in symptomatic, hormone-refractory prostate cancer: a randomised, multicentre, placebo-controlled phase II study
Nilsson, Sten ; Franzen, Lars ; Parker, Christopher ; Tyrrell, Christopher ; Blom, Rene ; Tennvall, Jan ^LU ; Lennernas, Bo ; Petersson, Ulf ; Johannessen, Dag C. and Sokal, Michael , et al. (2007) In The Lancet Oncology 8(7). p.587-594
- Contribution to journal › Article

your query:: Remove author: Parker, Christopher